JP2010510260A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510260A5
JP2010510260A5 JP2009537507A JP2009537507A JP2010510260A5 JP 2010510260 A5 JP2010510260 A5 JP 2010510260A5 JP 2009537507 A JP2009537507 A JP 2009537507A JP 2009537507 A JP2009537507 A JP 2009537507A JP 2010510260 A5 JP2010510260 A5 JP 2010510260A5
Authority
JP
Japan
Prior art keywords
skin
layer
transdermal therapeutic
therapeutic system
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009537507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510260A (ja
JP5881935B2 (ja
Filing date
Publication date
Priority claimed from DE102006054733A external-priority patent/DE102006054733A1/de
Application filed filed Critical
Publication of JP2010510260A publication Critical patent/JP2010510260A/ja
Publication of JP2010510260A5 publication Critical patent/JP2010510260A5/ja
Application granted granted Critical
Publication of JP5881935B2 publication Critical patent/JP5881935B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009537507A 2006-11-21 2007-11-09 活性物質の利用率及び用量精度の高い経皮治療システム Expired - Fee Related JP5881935B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006054733.0 2006-11-21
DE102006054733A DE102006054733A1 (de) 2006-11-21 2006-11-21 Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
PCT/EP2007/009707 WO2008061639A1 (de) 2006-11-21 2007-11-09 Transdermales therapeutisches system mit hoher wirkstoffausnutzungsrate und dosiergenauigkeit

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015229478A Division JP6109280B2 (ja) 2006-11-21 2015-11-25 活性物質の利用率及び用量精度の高い経皮治療システム

Publications (3)

Publication Number Publication Date
JP2010510260A JP2010510260A (ja) 2010-04-02
JP2010510260A5 true JP2010510260A5 (enExample) 2013-07-04
JP5881935B2 JP5881935B2 (ja) 2016-03-09

Family

ID=39060261

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009537507A Expired - Fee Related JP5881935B2 (ja) 2006-11-21 2007-11-09 活性物質の利用率及び用量精度の高い経皮治療システム
JP2015229478A Expired - Fee Related JP6109280B2 (ja) 2006-11-21 2015-11-25 活性物質の利用率及び用量精度の高い経皮治療システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015229478A Expired - Fee Related JP6109280B2 (ja) 2006-11-21 2015-11-25 活性物質の利用率及び用量精度の高い経皮治療システム

Country Status (16)

Country Link
US (3) US9056026B2 (enExample)
EP (1) EP2094213B1 (enExample)
JP (2) JP5881935B2 (enExample)
KR (1) KR101471216B1 (enExample)
CN (1) CN101522146B (enExample)
AU (1) AU2007323401C1 (enExample)
BR (1) BRPI0719006B8 (enExample)
CA (1) CA2662510C (enExample)
DE (1) DE102006054733A1 (enExample)
ES (1) ES2549692T3 (enExample)
IL (1) IL198714A0 (enExample)
MX (1) MX2009005343A (enExample)
NZ (1) NZ575043A (enExample)
RU (1) RU2454994C2 (enExample)
WO (1) WO2008061639A1 (enExample)
ZA (1) ZA200902579B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
DE102006054733A1 (de) * 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
DE102011114411A1 (de) * 2011-09-26 2013-03-28 Lts Lohmann Therapie-Systeme Ag Pflaster mit einstellbarer Okklusion
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
JP6726096B2 (ja) 2013-07-03 2020-07-22 エルテーエス ローマン テラピー−システメ アーゲー 電子部品を有する経皮治療システム
ES2954087T3 (es) 2014-05-20 2023-11-20 Lts Lohmann Therapie Systeme Ag Sistema de administración transdérmica que incluye un mediador de interfase
EP3145502B1 (en) 2014-05-20 2022-07-06 LTS Lohmann Therapie-Systeme AG Transdermal delivery system containing rotigotine
CA2948219C (en) 2014-05-20 2023-04-04 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
US20180263920A1 (en) * 2014-12-19 2018-09-20 3M Innovative Properties Company Transdermal drug delivery device including fentanyl
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
US20210393607A1 (en) * 2018-11-09 2021-12-23 Medrx Co., Ltd. Transdermal Patch Containing Fentanyl as Active Ingredient
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
WO2000033812A2 (en) 1998-12-07 2000-06-15 Elan Corporation, Plc Transdermal patch for delivering volatile liquid drugs
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10054479A1 (de) * 2000-11-03 2002-05-08 Henkel Kgaa Kosmetische Pflaster zur Hautaufhellung
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10110391A1 (de) 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
ES2276985T3 (es) * 2001-12-20 2007-07-01 Alza Corporation Dispositivo de electrotransporte que tiene una carcasa de deposito moldeada integralmente.
JP2003300873A (ja) * 2002-04-12 2003-10-21 Nitto Denko Corp 貼付剤およびその製造方法
AR033748A1 (es) 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
DE102004003224A1 (de) * 2003-02-07 2004-08-26 Lts Lohmann Therapie-Systeme Ag Für die Wärmeanwendung zur Beschleunigung der Permeation von Wirkstoffen geeignetes transdermales System und seine Verwendung
DE502004001897D1 (de) * 2003-02-07 2006-12-14 Lohmann Therapie Syst Lts Für die wärmeanwendung zur beschleunigung der permeation von wirkstoffen geeignetes transdermales therapeutisches system und seine verwendung
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US20050202073A1 (en) * 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
DE102005011517A1 (de) * 2005-03-10 2006-09-21 Grünenthal GmbH Transdermales therapeutisches System zur Verabreichung von Analgetika
DE102006026060B4 (de) 2006-01-12 2013-01-31 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme
US20070298961A1 (en) * 2006-06-22 2007-12-27 Rice Gordon L Method of producing electrodes
DE102006054733A1 (de) * 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit

Similar Documents

Publication Publication Date Title
JP2010510260A5 (enExample)
JP6109280B2 (ja) 活性物質の利用率及び用量精度の高い経皮治療システム
CN104144684B (zh) 含有多奈哌齐的经皮吸收制剂及其制备方法
KR101685736B1 (ko) 중합체 필름 내 약제의 결정화를 방지하는 방법
JP2016502989A5 (enExample)
CZ20032813A3 (cs) Transdermální náplast pro podání fentanylu
JP2016504368A5 (enExample)
JP7072520B2 (ja) 二重ディスク経皮システム
JP2011527697A5 (enExample)
KR20160108831A (ko) 남용 및 오용 저지 경피 시스템
US20140105979A1 (en) Compositions and methods for the transdermal delivery of methylphenidate
CN106659702A (zh) 透皮递送体系
KR101583680B1 (ko) 펜타닐의 1일-1회 교체 경피 투여
JP2011500604A5 (enExample)
JP6832287B2 (ja) ２層の接着層を含むオーバーテープを用いる経皮治療システム
CA2513402A1 (en) Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
JP5954919B2 (ja) 揮発性および／または熱不安定性物質用の経皮吸収治療システム
WO2007112287A3 (en) Hme transdermal compositions containing testosterone
JP2007513916A (ja) 架橋親水性重合体を基礎とする投与剤形
ZA200505629B (en) Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances and the use thereof
CN101304735A (zh) 用于挥发性和/或热不稳定的物质的经皮治疗体系
HK1132898A (en) Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
JPWO2021078761A5 (enExample)
JPS61251618A (ja) 外用医薬部材